Page 15 - D'Conner PRODUCT catalogue
P. 15

FORMULATION:
        Each vial contains:
        Cefuroxime Sodium …. 750 mg
        DESCRIPTION:
        It is a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration.
        MECHANISM OF ACTION:
        It is a bactericidal semi-synthetic cephalosporin antibiotic which is resistant to most beta-
        lactamases and it is active against wide range of gram-positive and gram- negative organisms.
        Pharmacokinetics:
        It is given intramuscularly or intravenously and has a half-life of 70 minutes in healthy patients
        but longer for patients who have renal impairment and in neonates. It is excreted in the urine
        within 6 hours.
        INDICATIONS:
              It can be used to treat infections of the lungs or chest, urinary tract, skin and soft tissue,
               abdomen.
              It can also be used in gonorrhea, meningitis, otitis media, peritonitis, pharyngitis,
               sinusitis and skin infections and as a prophylactic medication prior to surgeries
        PRECAUTIONS:
        You must not be given cefuroxime if you are allergic to any cephalosporin antibiotics and if
        you have ever had a severe allergic reaction to any other type of beta lactam antibiotic and in
        its other components
        SPECIAL WARNINGS AND PRECAUTIONS:
        You must look out for certain symptoms such as allergic reactions and gastrointestinal
        disorders such as diarrhea while you are being given cefuroxime. This will reduce the risk of
        possible problems.
        DRUG INTERACTIONS:
        Tell your doctor if you are taking any other medicines especially these following:
        aminoglycoside-type antibiotics, diuretics, Probenecid, Contraceptive pills, oral anticoagulants
        DOSAGE AND ADMINISTRATION:
        The correct dose will be decided based on the severity and type of infection, whether you are
        on any other antibiotics; your weight and age; and how well your kidneys are working.
               Newborn babies (0 – 3 weeks): For every 1 kg the baby weighs, they’ll be given 30 to 100
        mg cefuroxime per day divided in two or three doses.
               Babies (over 3 weeks) and children: For every 1 kg the baby or child weighs, they’ll be
               given 30 to 100 mg of cefuroxime per day divided in three or four doses.
               Adults and adolescents: 750 mg to 1.5 g of cefuroxime per day divided into two, three or
               four doses.
        Maximum dose: 6 g per day.
        SIDE EFFECTS:
                   Severe allergic reaction, fungal infections on rare occasions, injection site pain, swelling
        and redness along a vein, increases in liver enzymes and other blood related disorders
        INCOMPATIBILITIES:
        Solutions containing Cefuroxime should not be mixed with or added to solutions containing
        other agents other than those mentioned above.
        MANUFACTURED BY: Scott-Edil Advance Research Laboratories & Education Limited
        IMPORTED BY: Pharmakon Biotec Inc.
        EXCLUSIVELY DISTRIBUTED BY: D’ Conner Pharma
   10   11   12   13   14   15